cefepime Injection 500 mg, 1000 mg, 2000 mg
Dossier type
CTD
Dossier status
Ready to file
Country of origin
Egypt
GMP approvals
Egypt
Manufacturer #21899
This CTD dossier owner and manufacturer has been operating for over three decades, demonstrating a dedication to quality pharmaceutical manufacturing within the region. Their commitment to continuous improvement is evident in their adherence to stringent regulatory standards such as GMP, GLP, and WHO guidelines. They produce a wide range of generic medications across numerous therapeutic areas, including cardiology, orthopedics, and urology. Their focus extends to delivering high-quality medicines for both domestic and international markets, highlighting a dedication to global healthcare advancements. The company's portfolio includes Rx products in solid, liquid, and injectable dosage forms.
Cefepime is an antibiotic used to treat a wide range of bacterial infections, including intraabdominal, kidney, skin, urinary tract infections as well as pneumonia. Suppliers of cefepime market it in the form of powders for injectable solutions.
The developer and earliest manufacturer of cefepime is Bristol-Myers Squibb who first introduced it into the market in 1994 under the trade name Maxipime. Currently, major manufacturers of cefepime medications include companies such as Berr Chem, Hangzhou Viwa, Nectar Lifesciences, ACS Dobfar, and Qilu Pharmaceutical.
Cefepime suppliers and distributors market both generic and trade name formulations of the drug. Buyers are advised that online sellers may attempt to market fraudulent versions of the drug, whereas Pipeline Pharma, through its pre-auditing and quality control procedures ensures that only verified cefepime manufacturers and wholesalers enter our online marketplace, offering you a risk-free B2B pharmaceutical sales platform.
The retail prices per 10g of cefepime powder falls into an approximate range of 120 EUR to 160 EUR.